Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.485
-0.095 (-6.01%)
Mar 31, 2025, 2:31 PM EDT - Market open
Lucid Diagnostics Employees
Lucid Diagnostics had 70 employees as of December 31, 2023. The number of employees decreased by 4 or -5.41% compared to the previous year.
Employees
70
Change (1Y)
-4
Growth (1Y)
-5.41%
Revenue / Employee
$62,086
Profits / Employee
-$757,500
Market Cap
128.98M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 70 | -4 | -5.41% |
| Dec 31, 2022 | 74 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
LUCD News
- 4 days ago - Lucid Diagnostics Launches "Embrace the Future" Campaign Showcasing EsoCheck's Groundbreaking Collect+Protect Esophageal Cell Collection Technology - PRNewsWire
- 7 days ago - Lucid Diagnostics Inc. (LUCD) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results - PRNewsWire
- 11 days ago - Lucid Diagnostics Announces Updated National Comprehensive Cancer Network® (NCCN) Guidelines Now Include Esophageal Precancer Screening - PRNewsWire
- 13 days ago - Lucid Diagnostics' ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication - PRNewsWire
- 18 days ago - Lucid Diagnostics Secures First Positive Commercial Insurance Coverage Policy for its EsoGuard® Esophageal DNA Test - PRNewsWire
- 21 days ago - Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 24, 2025 - PRNewsWire
- 25 days ago - Lucid Diagnostics Announces Closing of $15.3 Million Registered Direct Offering - PRNewsWire